Relypsa: Relypsa Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14032018 Prices from USD $250

SummaryRelypsa Inc Relypsa a subsidiary of Vifor Pharma AG is a biopharmaceutical company that discovers develops and commercializes polymeric medicines. The company's lead product candidate includes veltassa a potassium binder approved for the treatment o...